======= SF3B5 =======
== Gene Information ==
* **Official Symbol**: SF3B5
* **Official Name**: splicing factor 3b subunit 5
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83443|83443]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BWJ5|Q9BWJ5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SF3B5&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SF3B5|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617847|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). {ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:27720643}.
|SF3b10|
|U2 snRNP|
|U12-type spliceosomal complex|
|U2-type precatalytic spliceosome|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions|
|RNA splicing|
|mRNA processing|
|mRNA metabolic process|
|RNA processing|
|RNA binding|
|RNA metabolic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.7|
|[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.7|
|[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.71|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|1.72|
|[[:results:exp153|SGC2096 2.6μM R03 exp153]]|1.77|
|[[:results:exp260|ABT-702 0.1μM R06 exp260]]|1.91|
|[[:results:exp464|Calcipotriol 5μM R08 exp464]]|2.19|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.455|
|[[:human genes:g:gar1|GAR1]]|0.434|
|[[:human genes:p:prim1|PRIM1]]|0.425|
|[[:human genes:o:orc1|ORC1]]|0.416|
|[[:human genes:t:tfip11|TFIP11]]|0.413|
|[[:human genes:s:sf3a2|SF3A2]]|0.413|
|[[:human genes:n:narfl|NARFL]]|0.408|
|[[:human genes:o:orc6|ORC6]]|0.404|
|[[:human genes:s:snrpa1|SNRPA1]]|0.402|
|[[:human genes:c:copg1|COPG1]]|0.402|
Global Fraction of Cell Lines Where Essential: 739/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|26/26|
|breast|33/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|75/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1431
* **Expression level (log2 read counts)**: 5.34
{{:chemogenomics:nalm6 dist.png?nolink |}}